Third dose of AstraZeneca vaccine produces more anti-omicron antibodies – Human – Science & Technology

The British-Swedish pharmaceutical company AstraZeneca said on Thursday that preliminary data from her study show that its anti-coronavirus vaccine Vaxzevria will be able to generate a greater immune response against various variants of the virus, including omicron, after receiving a third booster dose.

Reuters reported. The immune response to omicron as well as beta, delta, alpha and gamma increased after the third dose, not only in people who had been previously vaccinated with Vaxzevria but also in those who had received mRNA in the past.

Read also Omicron has a 90 percent lower mortality rate than the delta, according to research from the USA

AstraZeneca now plans to provide the data it collected to the world’s regulatory authorities, given the growing need to re-vaccinate people with the third dose. This is the first data published by the company in connection with its research into the third dose of Vaxzevria.

“These important studies show that third doses of Vaxzevri after two initial doses of the vaccine or after an mRNA vaccine or an inactivated vaccine significantly increase immunity against COVID-19,” said Andrew Pollard, head of the Oxford Vaccine Group.

omikron Read also WHO: Omicron causes a less severe course of covid, but it is dangerous

An extensive British study last December found that the third dose of the AstraZenca vaccine increased the number of antibodies when given after two doses of Vaxzevrie or Pfizer’s mRNA-based vaccine. However, this study also showed that the highest number of antibodies after the third dose was generated after the administration of mRNA vaccines from Pfizer and Moderna.

The Vaxzevria vaccine was developed by AstraZeneca in collaboration with Oxford University.

Source: Pravda – Veda a technika by

*The article has been translated based on the content of Pravda – Veda a technika by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!